DXC vs IBM: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
IBM is the larger of the two ($218.71B market cap): the incumbent the market prices for continued execution (17.65x forward earnings, beta 0.72). DXC is the smaller challenger ($2.18B), cheaper on forward earnings (4.61x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
DXC vs IBM: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | DXC | IBM | What it tells you |
|---|---|---|---|
| Market cap | $2.18B | $218.71B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 4.61 | 17.65 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 17.92 | 20.63 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.79 | 0.72 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 74% of range | 25% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.72 | 6.35 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: DXC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how DXC and IBM affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DXC and IBM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DXC and IBM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does DXC Technology (DXC) do?
DXC Technology was formed in 2017 from the merger of Computer Sciences Corporation (CSC) and the enterprise services arm of Hewlett Packard Enterprise. It manages and modernizes technology for large companies and governments in roughly 70 countries, through two main segments: Global Infrastructure Services (GIS), which runs data centers, cloud, workplace and security operations, and Consulting and Engineering Services (CES), which covers application development, analytics, engineering and industry software, plus a large insurance software and business process unit. Much of its work is long-term outsourcing contracts on mission-critical systems, which makes revenue sticky but also exposes it to steady erosion as clients renegotiate, insource or move work to cheaper rivals and hyperscale clouds. The scale is still large: DXC employs on the order of 120,000 people and counts many Fortune 500 banks, insurers, airlines, automakers and government agencies as clients, often for systems that cannot be switched off for even an hour.
What does International Business Machines (IBM) do?
International Business Machines (IBM) is one of the oldest and largest technology companies, now focused on enterprise software, consulting, and infrastructure. Its strategy centers on hybrid cloud and AI, anchored by Red Hat (the open-source software it acquired) and its watsonx AI platform. IBM's Software segment sells automation, data, security, and hybrid-cloud software, increasingly on a recurring subscription basis. Consulting provides large-scale technology and business services, helping enterprises modernize and adopt AI. Infrastructure includes IBM's mainframe systems (the zSystems that run mission-critical workloads for banks and large enterprises) and related storage. IBM makes money from a mix of recurring software, services contracts, and hardware tied to mainframe cycles. After years of slow growth, IBM has repositioned around hybrid cloud and AI, divested legacy businesses (spinning off Kyndryl), and emphasized recurring revenue and free cash flow. Founded in 1911 and headquartered in Armonk, New York, IBM is a mature, dividend-paying enterprise technology company. Revenue reached about $67.5 billion in 2025 and about $69.1 billion over the twelve months to June 2026, with net income of about $10.7 billion and free cash flow of about $12 billion. In the June 2026 quarter IBM reported revenue of about $17.2 billion and adjusted EPS of $2.93, exactly in line with consensus, after beating estimates in the three prior quarters. The shares fell about 21% in 2026 through mid-October, though they have recovered about 10% over the past three months.
DXC vs IBM: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- DXC drivers: Stabilizing bookings; AI-led modernization services.
- IBM drivers: Hybrid cloud with Red Hat; Enterprise AI with watsonx.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. For IBM, iBM is a mature company that has struggled to grow revenue much above low single digits, so the story depends on the higher-growth software and AI mix offsetting slower legacy areas.
DXC or IBM: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick DXC if you believe its drivers more; IBM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DXC and IBM guides.
DXC vs IBM: the full fundamentals
DXC. At about $13.79 a share (the October 15, 2026 close, within a 52-week range of roughly $7.90 to $15.68), DXC trades at about 4.8 to 5.7 times its guided non-GAAP earnings and a double-digit free cash flow yield, among the lowest multiples in large-cap IT services. That discount reflects years of shrinking revenue and repeated misses rather than an overlooked bargain by default, and analyst coverage in mid-2026 was uniformly at Hold with targets near $11. The next earnings report, for the September 2026 quarter, was expected around October 29, 2026, with options implying a move of roughly 15%. For comparison, larger rivals such as Accenture have historically traded at well over 20 times earnings, and even fellow turnaround Kyndryl has carried a materially higher multiple, which shows how much of DXC's discount is tied to its specific growth record rather than the sector as a whole.
IBM. As of October 16, 2026, IBM trades at about 21x trailing and 18x forward earnings, cheaper than at the start of the year after a roughly 21% decline in the share price, with a dividend yield near 2.9% and free cash flow of about $12 billion. Third-quarter results on October 21 carry a consensus of about $2.87 in adjusted EPS on roughly $16.8 billion of revenue, and analysts expect about 6% EPS growth for 2026. It remains valued more as a cash-flow and income story than a high-growth name.
Headline figures (approximate, October 2026): DXC shows revenue (ttm) ~$12.5 billion, fy2027 revenue guidance ~$12.1 to $12.35 billion (organic -3% to -5%), non-gaap eps guidance (fy2027) ~$2.40 to $2.90, free cash flow (fy2026) ~$713 million; IBM shows revenue (ttm) ~$69 billion, revenue growth (latest quarter, yoy) ~1% (Yahoo Finance basis), operating margin ~16.5%, net income (ttm) ~$10.7 billion.
The bottom line: DXC vs IBM
DXC and IBM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DXC and IBM exposure against your real portfolio. It is not an investment adviser.
Wondering how DXC or IBM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in DXC Technology with AI
Connect the broker you already use and ask Walnut's AI how DXC fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between DXC and IBM?
+
DXC Technology was formed in 2017 from the merger of Computer Sciences Corporation (CSC) and the enterprise services arm of Hewlett Packard Enterprise. International Business Machines (IBM) is one of the oldest and largest technology companies, now focused on enterprise software, consulting, and infrastructure. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is DXC or IBM the better stock?
+
Neither is universally better. IBM is the larger incumbent; DXC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, DXC or IBM?
+
On forward P/E (as of October 2026), DXC trades at 4.61x and IBM at 17.65x, so DXC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both DXC and IBM?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of DXC vs IBM?
+
DXC: The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. Generative AI could deflate pricing across IT services, hitting the labor-based maintenance work that makes up much of DXC's base. The company has a history of guidance misses, leadership turnover and restructuring charges, and law firms announced investigations after the May 2026 miss, though no new class action had been reported as filed as of October 2026. DXC also carries several billion dollars of debt and lease obligations, so a deterioration in cash flow would narrow its room for buybacks. Currency is another swing factor, since a large share of revenue comes from Europe, Australia and other non-US markets, so a stronger dollar reduces reported results. Finally, outsourcing renewals tend to come in lumps, and a quarter with several large contracts up for renegotiation can show price cuts that persist for the life of the new deal. IBM: IBM is a mature company that has struggled to grow revenue much above low single digits, so the story depends on the higher-growth software and AI mix offsetting slower legacy areas. Consulting is cyclical and sensitive to enterprise IT budgets. IBM competes against larger, faster-growing cloud and software rivals like Microsoft, Amazon, and Google, and its public-cloud presence is small. The Red Hat acquisition added debt, and total debt stood near $65 billion against about $8 billion of cash at mid-2026, and large past acquisitions carry integration and goodwill risk. Mainframe revenue is lumpy, tied to product cycles. Realizing the AI opportunity at scale is uncertain, and the stock's appeal rests heavily on cash flow and the dividend rather than rapid growth. The stock has also been volatile for a mature name: it traded between about $199 and $332 over the past year and was down about 21% year to date and 16% over one year as of October 16, 2026, so sentiment toward its software and AI story can shift quickly.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DXC or IBM; figures are approximate and dated (as of October 2026). Verify current data before investing.